Õ¬ÄÐÊÓƵ

XClose

UCL News

Home
Menu

EU regulator rejects Alzheimer's drug lecanemab

29 July 2024

"I am sure we will now see rich people with early Alzheimer’s disease flying to the US or other jurisdictions for treatment," says Professor Sir John Hardy (UCL Queen Square Institute of Neurology) who is critical of the EU's decision.

, , , ,Ìý